Patrick M. Schmidt
Despite a recent critical blood shortage and an overall decline in plasma donations since the beginning of the COVID-19 pandemic, U.S. supplies of immune globulin (IG) products derived from plasma remain stable, market experts told Specialty Pharmacy Continuum.
“This is the wrongest I’ve been in my career,” said Patrick M. Schmidt, the CEO of FFF Enterprises, a leading national wholesaler of plasma products, who had anticipated an IG supply